Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach.
Our Partners

British Heart Foundation

Queen Mary University of London

University of Oxford

FFG

MUI, Medizinischen Universität Innsbruck

UKE Hamburg

University Medicine Göttingen

UKD Dusseldorf

Mount Sinai

CARIM Maastricht